LDX — Lumos Diagnostics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- AU$149.70m
- AU$157.41m
- $12.40m
Annual cashflow statement for Lumos Diagnostics Holdings, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.191 | 0.017 | 0.021 | 0.516 | 1.21 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.9 | -18 | -9.64 | 0.946 | -9.33 |
| Capital Expenditures | -8.33 | -4.36 | -0.155 | -0.098 | -0.053 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | — | — | 4.46 | 0 | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -8.33 | -4.36 | 4.31 | -0.098 | -0.053 |
| Financing Cash Flow Items | — | — | -0.134 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 63.3 | -10.9 | 0.652 | 2.63 | 5.28 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 44 | -36.9 | -4.96 | 3.46 | -4.52 |